鲁大师免费观看日本电影,国产69精品久久久久熟女白洁,337p粉嫩大胆色噜噜噜,91视频在线免费观看
首頁 /科研細(xì)胞 /人源細(xì)胞系 /其他人源細(xì)胞系 /NCCIT(人畸胎瘤細(xì)胞)

NCCIT(人畸胎瘤細(xì)胞)

CBP61089

詢 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
I. General information 
Synonyms: NCCIT
Background: NCCIT was established by Shinichi Teshima (National Cancer Institute, Tokyo, Japan) in 1985 from a mediastinal mixed germ cell tumor.
Species: Homo sapiens, human
Tissue: anterior mediastinal mixed germ cell tumor
Disease: pluripotent embryonal carcinoma; teratocarcinoma
Gender: male, adult, Japanese
Morphology: epithelial
Growth Mode: adherent
Doubling Time: N/A
DNA Profile: Amelogenin: X
CSF1PO: 10,12
D13S317: 11
D16S539: 9,12
D5S818: 10,13
D7S820: 10
THO1: 7,9
TPOX: 8
vWA: 14,18
Our Cell Line Authentication Service
Culture Medium:

RPMI 1640+10% FBS

NCCIT完全培養(yǎng)基,# CBP61089M
We strongly suggest to purchase the complete medium from us.

Cryopreservation medium: 90%FBS+10%DMSO
Antigen Expression: N/A
Receptor Expression: N/A
Oncogene: N/A
Genes Expressed: N/A
Cellular Products: N/A
Tumor Formation: Yes, Tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 107 cells.
Comments:  
This pluripotent stem cell line is capable of somatic and extraembryonic differentiation.
The undifferentiated cells are equivalent to a stage intermediate between seminoma and embryonal carcinoma.
They will differentiate in response to retinoic acid.
NCCIT cells are negative for keratin.
They are positive for vimentin and placental alkaline phosphatase.
The line was contaminated with mycoplasma, but was cured by the depositor prior to deposit at the ATCC.
For more information, please contact us (4008-750-250).

客服

微信

掃一掃,添加二維碼

電話

留言

藥靶模型聯(lián)系方式: 華東銷售經(jīng)理:18240630236/15715191010 華中&華西銷售經(jīng)理:18071545918 華中&西南銷售經(jīng)理:13871580511 華北銷售經(jīng)理:18628311252 全國銷售經(jīng)理:13816461235
診斷標(biāo)準(zhǔn)品聯(lián)系方式: 華東銷售經(jīng)理:15000320447 華北銷售經(jīng)理:18628311252 華中&華西銷售經(jīng)理:18071545918 華中&西南銷售經(jīng)理:13871580511 全國銷售經(jīng)理:13816461235

掃二維碼

立即提交